BOTTOSSO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 898
NA - Nord America 885
EU - Europa 511
AF - Africa 227
SA - Sud America 170
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 2.716
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 773
SG - Singapore 345
CN - Cina 174
IT - Italia 125
BR - Brasile 119
HK - Hong Kong 106
VN - Vietnam 54
DE - Germania 48
FI - Finlandia 42
BJ - Benin 31
GB - Regno Unito 27
PL - Polonia 27
NL - Olanda 26
RU - Federazione Russa 19
AT - Austria 18
AR - Argentina 16
CZ - Repubblica Ceca 16
FR - Francia 16
ID - Indonesia 15
JP - Giappone 14
IN - India 12
EG - Egitto 11
ES - Italia 11
IQ - Iraq 11
PS - Palestinian Territory 11
SE - Svezia 11
CA - Canada 10
TR - Turchia 10
UZ - Uzbekistan 10
CY - Cipro 9
GT - Guatemala 9
IE - Irlanda 9
KR - Corea 9
MY - Malesia 9
SK - Slovacchia (Repubblica Slovacca) 9
ZA - Sudafrica 9
ZW - Zimbabwe 9
HN - Honduras 8
JO - Giordania 8
LC - Santa Lucia 8
ML - Mali 8
PK - Pakistan 8
DK - Danimarca 7
HR - Croazia 7
IL - Israele 7
MA - Marocco 7
MX - Messico 7
NP - Nepal 7
PY - Paraguay 7
RW - Ruanda 7
SO - Somalia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
UA - Ucraina 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
AO - Angola 6
AZ - Azerbaigian 6
BS - Bahamas 6
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GN - Guinea 6
JM - Giamaica 6
KZ - Kazakistan 6
MD - Moldavia 6
MG - Madagascar 6
MK - Macedonia 6
MW - Malawi 6
TZ - Tanzania 6
XK - ???statistics.table.value.countryCode.XK??? 6
YE - Yemen 6
AL - Albania 5
BB - Barbados 5
BE - Belgio 5
CD - Congo 5
CH - Svizzera 5
CR - Costa Rica 5
CV - Capo Verde 5
EC - Ecuador 5
EE - Estonia 5
HU - Ungheria 5
LB - Libano 5
MU - Mauritius 5
NI - Nicaragua 5
PA - Panama 5
PH - Filippine 5
RE - Reunion 5
SA - Arabia Saudita 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
BZ - Belize 4
CO - Colombia 4
CU - Cuba 4
CW - ???statistics.table.value.countryCode.CW??? 4
DM - Dominica 4
GA - Gabon 4
GF - Guiana Francese 4
GH - Ghana 4
Totale 2.542
Salva come PNG Salva come JPEG
Città #
Singapore 213
Ashburn 174
Hong Kong 96
Chandler 82
Beijing 63
Los Angeles 38
Cotonou 29
Helsinki 23
Ho Chi Minh City 22
Santa Clara 20
Boardman 19
Fairfield 19
Hefei 18
Munich 17
Buffalo 16
Cambridge 16
New York 16
Padova 15
Bytom 14
Chicago 13
Milan 13
Turku 12
Hanoi 11
San Diego 11
São Paulo 11
Wilmington 11
Seattle 10
Tashkent 10
Vienna 10
Warsaw 10
Brooklyn 9
London 9
Salt Lake City 9
Tokyo 9
Amman 8
Harare 8
Houston 8
Nuremberg 8
Olomouc 8
Rome 8
Castries 7
Kampala 7
Kigali 7
Medford 7
Montreal 7
Princeton 7
Seoul 7
Abidjan 6
Antananarivo 6
Bamako 6
Conakry 6
Dublin 6
Nassau 6
Phoenix 6
Baghdad 5
Boston 5
Bridgetown 5
Ciudad del Este 5
Dallas 5
Denver 5
Guatemala City 5
Hargeisa 5
Kuala Lumpur 5
Lappeenranta 5
Luanda 5
Managua 5
Menouf 5
Miami 5
Roxbury 5
San José 5
Shanghai 5
Addis Ababa 4
Ann Arbor 4
Baku 4
Bratislava 4
Brussels 4
Cairo 4
Chaguanas 4
Chennai 4
Copenhagen 4
Dakar 4
Dar es Salaam 4
Des Moines 4
Haiphong 4
Johannesburg 4
Kingston 4
Kinshasa 4
Libreville 4
Lilongwe 4
Lusaka 4
Nicosia 4
Padua 4
Panama City 4
Pristina 4
Ramallah 4
San Francisco 4
Sterling 4
Turin 4
Villafranca Padovana 4
Willemstad 4
Totale 1.408
Salva come PNG Salva come JPEG
Nome #
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 182
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 179
Evolution of HER2-low expression from primary to recurrent breast cancer 168
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 154
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 150
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer 149
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 148
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications 147
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 146
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 145
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 129
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial 123
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability? 119
Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival 113
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 110
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort 108
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 106
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 105
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 90
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome 66
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome 64
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications 42
Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis 7
Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes 3
Temporal evolution of breast cancer brain metastases treatments and outcomes 1
Totale 2.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.973
article - articoli 9.973
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 5 5 2 10 2 0 2
2021/202285 0 0 3 4 8 8 18 3 4 5 7 25
2022/2023176 22 19 9 27 14 20 9 9 28 2 15 2
2023/2024204 15 21 17 12 23 25 25 8 6 13 21 18
2024/2025776 1 60 28 31 68 34 27 66 54 63 138 206
2025/20261.482 211 149 379 413 323 7 0 0 0 0 0 0
Totale 2.754